Amrize’s (AMRZ) “Underperform” Rating Reiterated at Bank of America

Bank of America restated their underperform rating on shares of Amrize (NYSE:AMRZ) in a report released on Wednesday, Marketbeat Ratings reports. The firm currently has a $40.00 target price on the stock, down from their prior target price of $50.00.

A number of other research analysts have also recently weighed in on the company. Wells Fargo & Company lowered their price objective on Amrize from $65.00 to $58.00 and set an “overweight” rating on the stock in a research report on Wednesday, July 8th. Oppenheimer decreased their target price on shares of Amrize from $68.00 to $65.00 and set an “outperform” rating on the stock in a research note on Tuesday, July 21st. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Amrize in a report on Friday, June 26th. Truist Financial reiterated a “hold” rating and issued a $48.00 price target (down from $65.00) on shares of Amrize in a research report on Tuesday, July 7th. Finally, Morgan Stanley set a $63.00 price objective on shares of Amrize and gave the stock an “overweight” rating in a research note on Monday, June 22nd. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, seven have given a Hold rating and three have given a Sell rating to the stock. According to MarketBeat, Amrize presently has a consensus rating of “Hold” and an average target price of $56.38.

Amrize Price Performance

Shares of Amrize stock opened at $43.83 on Wednesday. The stock has a market cap of $24.24 billion, a P/E ratio of 20.20, a P/E/G ratio of 1.23 and a beta of 0.04. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.73 and a current ratio of 1.10. The stock’s fifty day moving average is $48.41 and its 200 day moving average is $53.24. Amrize has a one year low of $41.61 and a one year high of $65.94.

Amrize (NYSE:AMRZ) last released its quarterly earnings results on Thursday, August 6th. The company reported $0.88 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.92 by ($0.04). The company had revenue of $3.49 billion for the quarter. Amrize had a net margin of 9.89% and a return on equity of 10.22%. Sell-side analysts anticipate that Amrize will post 2.72 earnings per share for the current year.

Amrize Announces Dividend

The business also recently disclosed a dividend, which was paid on Wednesday, August 26th. Stockholders of record on Tuesday, August 18th were given a dividend of $0.11 per share. The ex-dividend date was Tuesday, August 18th. Amrize’s dividend payout ratio (DPR) is presently 20.28%.

Insider Activity

In related news, insider Jaime Hill bought 1,500 shares of the stock in a transaction dated Tuesday, August 11th. The shares were purchased at an average price of $47.12 per share, with a total value of $70,680.00. Following the completion of the acquisition, the insider owned 29,698 shares of the company’s stock, valued at $1,399,369.76. This represents a 5.32% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Jacques Sanche bought 4,150 shares of the company’s stock in a transaction that occurred on Wednesday, August 26th. The shares were bought at an average price of $45.02 per share, with a total value of $186,833.00. Following the transaction, the director owned 9,766 shares of the company’s stock, valued at $439,665.32. The trade was a 73.90% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Over the last 90 days, insiders have purchased 48,983 shares of company stock valued at $2,158,755. Company insiders own 0.54% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. Geode Capital Management LLC bought a new stake in shares of Amrize in the second quarter worth about $265,000. M&T Bank Corp purchased a new stake in shares of Amrize in the second quarter worth about $205,000. Arrowstreet Capital Limited Partnership bought a new position in Amrize during the second quarter valued at approximately $3,870,000. Gabelli Funds LLC bought a new position in Amrize during the second quarter valued at approximately $1,083,000. Finally, AXA S.A. purchased a new position in Amrize during the 2nd quarter valued at approximately $1,065,000.

Amrize Company Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.